136 related articles for article (PubMed ID: 20955381)
1. HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study.
Sek P; Zawrocki A; Biernat W; Piekarski JH
Histopathology; 2010 Oct; 57(4):564-71. PubMed ID: 20955381
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
[TBL] [Abstract][Full Text] [Related]
3. [Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression].
Petrov SV; Raskin GA; Khasanov RSh; Tsyplakov DE
Arkh Patol; 2006; 68(5):10-4. PubMed ID: 17144522
[TBL] [Abstract][Full Text] [Related]
4. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
Meissner K; Rivière A; Haupt G; Löning T
Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
[TBL] [Abstract][Full Text] [Related]
5. [Expression status of HER2 in mammary and extramammary Paget's disease].
Meng H; Zheng XY; Zhang L; Li WC
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
[No Abstract] [Full Text] [Related]
6. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
[TBL] [Abstract][Full Text] [Related]
7. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
Liegl B; Horn LC; Moinfar F
Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
[TBL] [Abstract][Full Text] [Related]
10. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
[TBL] [Abstract][Full Text] [Related]
11. Paget's disease in contralateral breast occuring 11 years after mastectomy for invasive ductal carcinoma.
Salopek D; Murgić J; Tomas D; Bolanca A; Kusić Z
Coll Antropol; 2009 Mar; 33(1):327-9. PubMed ID: 19408647
[TBL] [Abstract][Full Text] [Related]
12. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F
Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
[TBL] [Abstract][Full Text] [Related]
13. Mammary Paget's disease and associated carcinoma. An immunohistochemical study.
Cohen C; Guarner J; DeRose PB
Arch Pathol Lab Med; 1993 Mar; 117(3):291-4. PubMed ID: 7680194
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
[TBL] [Abstract][Full Text] [Related]
15. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
Horn LC; Purz S; Krumpe C; Bilek K
Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
[TBL] [Abstract][Full Text] [Related]
16. Glandular Paget's disease of the nipple.
Shousha S
Histopathology; 2007 May; 50(6):812-4. PubMed ID: 17376174
[No Abstract] [Full Text] [Related]
17. Minimally invasive mammary Paget's disease without an underlying breast carcinoma.
Hanna M; Jaffer S; Bleiweiss IJ; Nayak A
Virchows Arch; 2013 Sep; 463(3):471-3. PubMed ID: 23851623
[No Abstract] [Full Text] [Related]
18. HER2 oncogene amplification in extramammary Paget's disease.
Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
[TBL] [Abstract][Full Text] [Related]
19. Toker-cell pathology as a unifying concept.
Fernandez-Flores A
Histopathology; 2008 Jun; 52(7):889-91; author reply 891-2. PubMed ID: 18462365
[No Abstract] [Full Text] [Related]
20. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
